Investors.alvotech.com

Investors Overview

WebOverview. Alvotech is a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a …

Actived: 1 days ago

URL: https://investors.alvotech.com/

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ …

WebSELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva …

Category:  Health Go Health

investors.alvotech.com

WebREYKJAVIK, Iceland and BOUCHERVILLE, Quebec, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development …

Category:  Health Go Health

Alvotech Expands its Board of Directors as part of Transition from

WebFour new members enhance independence and diversity of Board of Directors Alvotech is dual listed on NASDAQ in the U.S. and NASDAQ First North Growth Market …

Category:  Health Go Health

Alvotech and Fuji Pharma Expand Partnership Adding a New …

WebThe exclusive partnership agreement was first announced by Alvotech and Fuji in November 2018, and previously extended in December 2020 and February 2022, …

Category:  Health Go Health

Alvotech Reaches Primary Completion Date in its Switching Study …

WebAlvotech’s Proposed Interchangeable Product for High-Concentration Humira® Could Save U.S. Consumers and Taxpayers Billions Annually In May of 2021, …

Category:  Health Go Health

Alvotech enters into commercialization agreement with …

WebAlvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept) May 10, 2023 Polifarma will commercialize AVT06, a proposed …

Category:  Health Go Health

Alvotech and JAMP Pharma Announce Receipt of Marketing …

WebPr Jamteki TM is the second biosimilar developed under this partnership that receives marketing authorization in Canada.. REYKJAVIK, Iceland and …

Category:  Health Go Health

Alvotech’s Partner Submits Application for Marketing Approval of …

WebREYKJAVIK, Iceland, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar …

Category:  Health Go Health

Alvotech & CCHT Biopharmaceutical and Yangtze River …

WebCAHT was founded in March 2019 as a joint venture between Alvotech and CCHT, Changchun, China. CAHT is building a state-of-the art biopharmaceutical facility …

Category:  Health Go Health

Alvotech enters into commercialization agreement with Polifarma …

WebPolifarma will commercialize AVT06, a proposed biosimilar to Eylea ® (aflibercept), in Turkey; REYKJAVIK, Iceland, May 10, 2023 (GLOBE NEWSWIRE) -- …

Category:  Health Go Health

Alvotech and JAMP Pharma Enter Into an Exclusive Partnership

WebJanuary 14, 2020. PDF Version. Alvotech and JAMP Pharma have entered into an agreement for an exclusive partnership to supply and commercialize five leading …

Category:  Health Go Health

Alvotech Reports Financial Results for Full Year 2022 and Provides

WebFinancial Results for Full Year 2022. Cash position and sources of liquidity. As of December 31, 2022, the Company had cash and cash equivalents of $66.4 million. In addition, the …

Category:  Health Go Health

Alvotech and Bioventure Announce Approval of AVT02 …

WebAlvotech handles development and manufacturing, while Bioventure is responsible for commercialization. The partnership earlier announced the approval of …

Category:  Health Go Health

Alvotech Reports First Half 2022 Financial Results and Business …

WebFinancial Results for First Half 2022. As of June 30, 2022, the Company had $128.4 million in cash and cash equivalents. In addition, the Company had borrowings of …

Category:  Health Go Health

Alvotech and Bioventure Announce Approval of AVT02 …

WebAVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure; REYKJAVIK, Iceland and DUBAI, United …

Category:  Health Go Health

Alvotech and Cipla Gulf into a Partnership

WebUnder the partnership, Alvotech will be responsible for development and supply of the product, while Cipla Gulf will be responsible for registration and …

Category:  Health Go Health

Alvotech Appoints Sarah Tanksley as Chief Quality Officer

WebREYKJAVIK, Iceland, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar …

Category:  Health Go Health

Alvotech Receives Manufacturing License for its Biopharmaceutical

WebAlvotech is delighted to announce that it has received manufacturing licensure from the Icelandic Medicines Agency, for its biopharmaceutical facility in …

Category:  Medicine Go Health